Janice Ann Koval, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2841 Debarr Rd Ste 50, Anchorage, AK 99508 Phone: 907-276-2811 Fax: 907-276-2810 |
Jeanne R Bonar, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr, #523, Anchorage, AK 99508 Phone: 907-569-1049 Fax: 907-563-4564 |
Dr. Jeffrey Dale Medland, DO Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2841 Debarr Rd, Suite 43, Anchorage, AK 99508 Phone: 907-274-7847 Fax: 907-274-7845 |
Jerry Ross Tanner Ii, D.O. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2841 Debarr Rd Ste 43, Anchorage, AK 99508 Phone: 907-274-7847 Fax: 907-274-7845 |
Konrad C Kaltenborn, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 3260 Providence Dr, #523, Anchorage, AK 99508 Phone: 907-222-1714 Fax: 907-222-1724 |
News Archive
Dialysis treatments do not affect the heart health of kidney disease patients who have had a heart attack, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Since cardiovascular disease is the most common cause of death in kidney disease patients, the findings are good news for individuals who need the treatments.
The University of New Mexico Women's Basketball team will generously pay tribute to the courageous women battling breast cancer in our state as they have year after year. Along with the support of UNM Cancer Center, UNM Hospitals and UNM Athletics, the Lady Lobos will face the University of Nevada, Reno Wolf Pack on Valentine's Day for the annual "Lobos Love Pink" basketball game for breast cancer awareness.
Politico reports that federal officials made the emergency payment to Verizon Terremark after discovering the federal website was unable to handle sufficient traffic. Also in the news, the Maryland House is scheduled to vote on legislation to provide insurance to people who tried unsuccessfully to buy coverage through the state website.
Daiichi Sankyo Company, Limited today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor edoxaban compared to enoxaparin/warfarin for the prevention of stroke and other blood clot complications in patients with non-valvular atrial fibrillation (NVAF) undergoing electrical cardioversion (low-energy shocks to trigger normal heart rhythm).
Committed to providing the solutions labs need to meet the challenges they face, Beckman Coulter Diagnostics has been ranked among the industry's highest performing Service providers in the clinical diagnostics industry in the 2014 IMV ServiceTrak Executive Summary Report.
› Verified 9 days ago